Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE

• William Stohl,
• Milena Kurtinecz,
• David A Roth,
• Herbert Struemper,
• William W Freimuth,
• Lisa Edwards

Affiliations

William Stohl

Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA

Milena Kurtinecz

Biostatistics, GlaxoSmithKline, Collegeville, Pennsylvania, USA (At the time of the study)

David A Roth

Research & Development, GlaxoSmithKline, Collegeville, South Carolina, USA

Herbert Struemper

Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, Research Triangle Park, North Carolina, USA

William W Freimuth

Freimuth Biopharmaceutical Consulting, Gaithersburg, Maryland, USA (At the time of the study)

Lisa Edwards

Biostatistics, GlaxoSmithKline, Chapel Hill, North Carolina, USA (At the time of the study)